Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hogy Medical Co ( (JP:3593) ) has shared an announcement.
Hogy Medical reported consolidated net sales of ¥28.7 billion for the nine months ended December 31, 2025, a 4.3% year-on-year decline, with operating profit down 38.7% to ¥2.09 billion and profit attributable to owners of parent falling 47.4% to ¥1.44 billion. Despite the earnings deterioration and lower comprehensive income, the company’s financial position remains solid, with an equity-to-asset ratio rising to 78.8% and net assets per share edging up, while it maintains its full-year forecast of modest 0.3% sales growth and a sharp drop in operating profit, alongside an annual dividend forecast of ¥47.50 per share, signaling a cautious but stable stance for shareholders amid profit pressure.
The most recent analyst rating on (JP:3593) stock is a Hold with a Yen6991.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.
More about Hogy Medical Co
Hogy Medical Co., Ltd. is a Japan-based medical supplies manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The company operates under Japanese GAAP and focuses on providing products and services to the healthcare sector, positioning itself as a key player in medical consumables and related solutions for hospitals and medical institutions.
Average Trading Volume: 179,322
Technical Sentiment Signal: Buy
Current Market Cap: Yen144.2B
Learn more about 3593 stock on TipRanks’ Stock Analysis page.